3Treitman AN, Yamold PR, Warren J, et al. Emerging incidence of Enterococcus faecium among hospital isolates( 1993 to 2002). J Clin Microbiol, 2005,43:462-463.
5Simonsen GS, Smabrekke L, Monnet DL, et al. Prevalence of resistance to ampicillin,gentamicin and vancomycin in enterococcus faecalis and enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals. J Antimicrob Chemother, 2003,51 : 323-231.
4Patrick R.Murray, editor in chief. Manual of Clinical Microbiology[M]. Sixth Edition ASM press 1995, 308.
5Biavaseo F, Giovanetti E, Miele A, et al. In vitro conjugative transfer of vanA vaneomycin resistance between Enterococci and Listeria of different species [ J]. Eur J Clin Microbiol Infect Dis, 1996,15( 1 ) :50.
6Boyce J M, Opal S M,Chow J W, et al . Outbreak of multidrug resistant Enterococcus faecium with transferable vanB class vancomycin resistance [J]. J Clin Microbiol , 1994,32:1148.
7Tenover F C, Tokars J, Swenson J, et al. Ability of clinical laboratories to detect antimicrobial agent- resistant Enterococci [J]. J Clin Microbiol, 1993,31 : 1695.
8David E, Perlada A, George S, et al. Molecular epidemiology and antibiotic susceptibility of Enterococci in Cincinnati, Ohio: a prospective citywide survey [J]. J Clin Microbiol, 1997, 35 (9): 2342.
9Appelbaum P C. Antimierobiol resistance in Streptococcus pneumomiae: all overview [J]. Clin Infect Dis, 1992,15:77.
10Shinabarger D L, Marotti K R, Murray R W, et al. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions [J]. Antimicrob Agents Chemother, 1997,41(10):2132.
2Jian-Dang Zhou, Jian-Jun Guo, Qin Zhang, Yin Chen, Shai-Hong Zhu and Huai-Yan Peng Department of Clinical Laboratory Institute of Organ Transplantation the Third Xiangya Hospital of Central South University,Department of Medical Laboratories College of Medical Technology and Information of Central South University, Changsha 410013, China.Drug resistance of infectious pathogens after liver transplantation[J].Hepatobiliary & Pancreatic Diseases International,2006,5(2):190-194. 被引量：3
6Clinical and laboratory standards institute (CLSI). Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement [S]. M100-S18, 2008, 28:43-45.
7Jones RN, Fritsche TR, Sader HS, et al. Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006 : an activity and spectrum analysis of linezolid using clinical isolates from 16 countries [J]. Diagn Microbiol Infect Dis, 2007, 59 (2) : 199 -209.
